HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China flag China · Delayed Price · Currency is CNY
3.620
+0.010 (0.28%)
Apr 29, 2026, 3:04 PM CST

SHE:002437 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
8,0726,8525,6775,5175,5836,397
Market Cap Growth
34.52%20.71%2.89%-1.18%-12.72%-9.06%
Enterprise Value
7,1646,1155,2775,4305,7946,481
Last Close Price
3.623.072.492.512.542.91
PE Ratio
19.5918.1824.3945.85-142.01
Forward PE
-24.5524.5524.5524.5524.55
PS Ratio
3.803.212.332.101.802.03
PB Ratio
3.363.152.883.233.283.23
P/TBV Ratio
4.334.244.015.015.365.36
P/FCF Ratio
37.03-16.3122.5624.4226.69
P/OCF Ratio
33.69-13.8120.1221.3423.33
EV/Sales Ratio
3.372.862.162.071.862.06
EV/EBITDA Ratio
23.01-16.0419.7126.8725.45
EV/EBIT Ratio
25.0715.1023.4231.5867.6856.03
EV/FCF Ratio
32.86-15.1622.2025.3527.04
Debt / Equity Ratio
0.010.030.000.400.850.79
Debt / EBITDA Ratio
0.07-0.012.456.755.99
Debt / FCF Ratio
0.10-0.012.766.376.50
Net Debt / Equity Ratio
-0.38-0.35-0.26-0.020.100.03
Net Debt / EBITDA Ratio
---1.55-0.130.770.25
Net Debt / FCF Ratio
-4.25--1.46-0.150.730.26
Asset Turnover
0.71-0.820.730.710.68
Inventory Turnover
6.01-6.005.424.812.30
Quick Ratio
1.57-0.800.670.670.68
Current Ratio
1.90-1.070.820.780.82
Return on Equity (ROE)
19.11%18.16%13.17%7.54%-15.72%2.75%
Return on Assets (ROA)
5.93%-4.71%2.97%1.22%1.57%
Return on Invested Capital (ROIC)
18.35%25.84%12.27%7.06%4.38%3.27%
Return on Capital Employed (ROCE)
11.70%-11.30%9.90%4.90%5.70%
Earnings Yield
5.10%5.50%4.10%2.18%-5.22%0.70%
FCF Yield
2.70%-6.13%4.43%4.09%3.75%
Payout Ratio
0.36%-4.02%36.41%-157.49%
Buyback Yield / Dilution
1.96%3.07%-2.82%-0.05%-0.07%0.04%
Total Shareholder Return
1.96%3.07%-2.82%-0.05%-0.07%0.04%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.